Download Citation
Article Source:
Ivermectin inhibits ER, HER2, and TGF-β pathways in ER-positive and endocrine-resistant breast cancer cells
Rujimongkon K,
Adchariyasakulchai P,
Boonyaratsewee C,
Horpratraporn K,
Ketchart W
(2026)
Ivermectin inhibits ER, HER2, and TGF-β pathways in ER-positive and endocrine-resistant breast cancer cells.
PLOS ONE 21(4): e0348260.
https://doi.org/10.1371/journal.pone.0348260